Giovana Lais Ruviaro Tuleski

Giovana Lais Ruviaro Tuleski

Auto-generated profile, based on publicly available information

Giovana Lais Ruviaro Tuleski

Laboratory of Comparative Cardiology, Department of Veterinary Medicine, Federal University of Parana (UFPR), Curitiba, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in Journal of Feline Medicine and Surgery
Verified
Journal Article
Closed access
GTGiovana Lais Ruviaro Tuleski
Giovana Lais Ruviaro Tuleski
MSMatheus Folgearini Silveira
Matheus Folgearini Silveira
RBRodrigo Franco Bastos
Rodrigo Franco Bastos
MPMaria Jose Garcia Ribeiro Pscheidt
Maria Jose Garcia Ribeiro Pscheidt
WPWiliam da Silva Prieto
Wiliam da Silva Prieto
MSMarlos G Sousa
Marlos G Sousa
Objectives: The aim of this study was to verify whether a single oral dose of gabapentin (100 mg) or melatonin (3 mg) given 60 mins before a cardiac evaluation would reduce anxiety without interfering with heart rate (HR), systemic blood pressure (SBP), electrocardiogram (ECG) and echocardiographic indexes. Methods: Seventy-five client-owned healthy cats underwent two sets of cardiac assessments 60 mins apart, randomly divided into gabapentin, melatonin and placebo groups. The interval between treatment and the second ECG and SBP measurement was 60 mins, and 70 mins for echocardiography. A compliance score (CS) classified the behavior, focusing on the ease of handling. Results: Most variables did not change between the examinations. The placebo group showed more significant changes (SBP, tricuspid annular plane systolic excursion, HR during echocardiography, aortic flow velocity, S′ wave from lateral mitral annulus), but they were not considered to be hemodynamically relevant. Gabapentin and melatonin significantly increased the cats’ compliance without interfering with cardiac assessment. Eight cats presented with mild sedation, seven after gabapentin and one after melatonin. No major side effects were observed. Conclusions and relevance: Gabapentin tranquilized the cats when it was given 60 mins prior to ECG and SBP measurement, and 70 mins prior to echocardiography, without interfering with systolic echocardiographic indexes. Melatonin also decreased the CS, but without sedation in most cases. The waiting period may have relaxed the cats in the placebo group, resulting in lower SBP measurements. However, this tranquility did not last as some echocardiographic changes signaled a sympathetic predominance.

6 February 2023 in Journal of Feline Medicine and Surgery
Verified
Journal Article
Open access
RBRodrigo Franco Bastos
Rodrigo Franco Bastos
GTGiovana Lr Tuleski
Giovana Lr Tuleski
MSMarlos Gonçalves Sousa
Marlos Gonçalves Sousa
Objectives: Hypertrophic cardiomyopathy (HCM) is the most common heart disease in cats. Electrocardiographic (ECG) analysis can help with the diagnosis of HCM and also in the investigation of the secondary consequences of the disease. This study investigated ECG markers of QT interval variability (total instability [TI], short-term instability [STI], long-term instability [LTI], QT variance [QTv]), mean QT interval (QTa) and QT interval corrected for heart rate (QTac), as well as the duration (QRSd) and dispersion (QRSv) of the QRS interval in healthy cats and in those with HCM. Methods: Data were collected from 63 domestic cats: 40 in the control group and 23 in the HCM group. Fifty consecutive QT intervals were recorded for all cats and then QTa, QTac, QTv, TI, LTI and STI were calculated. QRSd and QRSv were also obtained for all animals. A Mann–Whitney U-test was used for group comparison. Receiver operating characteristic curves were plotted to evaluate the sensitivity and specificity of all markers for HCM. Logistic regression analysis was performed to assess the risks of cats having HCM, based on the studied indexes. Results: QTa ( P <0.01), QTac ( P <0.01), QRSd ( P 158.8 ms, QTac >27.4 ms and QRSd >0.045 s had an accuracy of 77.4%, 68.2% and 80.9%, respectively, in detecting HCM. Logistic regression showed that cats with QTa >158 ms, QTac >27.4 ms and QRSd >0.045 s had a 1.58-, 1,23- and 6.5-fold higher risk, respectively, of developing HCM. Conclusions and relevance: Cats with HCM had higher ventricular instability as assessed by STI and showed a prolongation of the QT and QRS intervals via the QTa, QTac and QRSd markers. These markers show potential as ancillary screening tools for identifying the presence of HCM.

8 March 2022 in Veterinary Research Communications
Verified
Journal Article
Closed access
PDF file
GTGiovana Lais Ruviaro Tuleski
Giovana Lais Ruviaro Tuleski
MWMarcela Wolf
Marcela Wolf
MPMaria Jose Garcia Ribeiro Pscheidt
Maria Jose Garcia Ribeiro Pscheidt
JSJúlio Pereira dos Santos
Júlio Pereira dos Santos
MSMarlos Gonçalves Sousa
Marlos Gonçalves Sousa

26 April 2022 in Journal of Feline Medicine and Surgery
Verified
Journal Article
Closed access
GTGiovana Lr Tuleski
Giovana Lr Tuleski
MPMaria Jose Garcia Ribeiro Pscheidt
Maria Jose Garcia Ribeiro Pscheidt
JSJúlio Pereira dos Santos
Júlio Pereira dos Santos
MSMarlos Gonçalves Sousa
Marlos Gonçalves Sousa
Objectives: The aim of this study was to ascertain the effect of a drop of timolol 0.5% ophthalmic solution on the systolic function of the left ventricle (LV) and left atrium (LA), and to confirm if timolol helped appraisal of diastolic function by reducing heart rate (HR) and separating the transmitral outflow waves from tissue Doppler imaging (TDI). Methods: A total of 41 client-owned healthy cats underwent two echocardiograms 20 mins apart. The timolol group (33 cats) received a drop of timolol solution after the first examination. Standard and speckle-tracking echocardiography evaluated the LV and LA function of both groups at the two time points evaluated. Results: Timolol reduced HR (19%), and fractional shortening from LV (20.3%) and LA (16.6%). Septal S' decreased by 51% (from 7.7 to 5.2 cm/s) and lateral S’ dropped by 43.1% (7.3 to 5.1 cm/s). Most longitudinal techniques did not change after timolol, including the mitral annular plane systolic excursion from the interventricular annulus, tricuspid annular plane systolic excursion, LV longitudinal strain and LV tissue motion annular displacement. The isovolumic relaxation time increased by 15.2% (from 54 to 64.6 ms), with most cats presenting this variable above the reference (>60 ms). Timolol did not support diastolic assessment, enabling evaluation in only 2/11 cats when using lateral TDI and 1/9 cats using septal TDI. Regarding side effects, miosis occurred in 18 cats (54.5%). Conclusions and relevance: Timolol reduced systolic function, decreasing standard echocardiographic variables. Regarding diastolic evaluation, although timolol decreased HR, it did not separate the mitral diastolic waves, as expected.

2 October 2025 in Archives of Veterinary Science
Verified
Journal Article
Open access
EBEdwin Fernando Buriticá-gaviria
Edwin Fernando Buriticá-gaviria
ELElizabeth De Almeida Licke da Luz
Elizabeth De Almeida Licke da Luz
FAFrancelli Ambrosini
Francelli Ambrosini
GTGiovana Lais Ruviaro Tuleski
Giovana Lais Ruviaro Tuleski
MSMarlos Gonçalves Sousa
Marlos Gonçalves Sousa
Brachycephalic obstructive airway syndrome (BOAS) is a condition characterized by anatomical obstructions of the upper airways that impair airflow and lead to ventilatory dysfunction in dogs with broad and short skulls. This condition may also contribute to the occurrence of arrhythmias associated with increased vagal tone, such as sinus pauses or atrioventricular blocks. In advanced stages, pulmonary hypertension and cardiac remodeling may occur, predisposing affected dogs to more complex arrhythmias, including atrial fibrillation. This study aimed to map the available scientific evidence regarding autonomic cardiac activity and the presence of arrhythmias in brachycephalic dogs. This scoping review was conducted according to the standards of the Joanna Briggs Institute (JBI) and adhered to the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews methodological guidance (PRISMA-ScR). The databases CABI, BVS, Embase, MEDLINE/PubMed, SciELO, Scopus, and Web of Science. were used to search for scientific evidence published to date. The search strategy included the terms: “airway obstruction”, “brachycephalic dogs”, “heart rate variability”, “parasympathetic nervous system”, and “respiratory sinus arrhythmia”. The research identified 769 articles, of which 11 met the criteria and were included. Each article was analyzed, and its information was characterized according to four domains of interest: general study information, methodological design of the studies, variables analyzed and diagnostic strategies applied, and main findings and conclusions. This scoping review emphasizes the increasing scientific interest in the relationship between brachycephalic breed morphology and cardiac autonomic modulation in dogs. Although there are a limited number of studies with methodological diversity, the evidence suggests that vagal overstimulation resulting from chronic upper airway obstruction in these breeds significantly influences heart rate and rhythm modulation. Future research should focus on achieving methodological standardization, detailed morphometric evaluations, and utilizing long-term monitoring techniques to improve diagnostic accuracy and clinical relevance.

4 May 2026 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
EBEdwin Fernando Buriticá-gaviria
Edwin Fernando Buriticá-gaviria
GTGiovana L R Tuleski
Giovana L R Tuleski
JSJoelma F Santos
Joelma F Santos
MEMariangela Endrighi
Mariangela Endrighi
MSMarlos G Sousa
Marlos G Sousa
Background: Brachycephalic obstructive airway syndrome (BOAS) affects the upper airways of brachycephalic dogs and might alter heart rate variability (HRV). Hypothesis/Objectives: This study aimed to evaluate HRV in dogs with BOAS during wakefulness and sleep. Animals: Forty-six client-owned dogs: 34 brachycephalic (with and without BOAS) and 12 non-brachycephalic controls. Methods: A prospective cross-sectional study utilizing 24-h Holter monitoring and segments recorded during wakefulness and sleep. The evaluated variables included heart rate, mean RR interval, the longest sinus pause, and HRV indices calculated over 24 h, as well as during segments of wakefulness and sleep: corrected standard deviation of NN intervals (cSDNN), corrected root mean square of successive differences (cRMSSD), the vagal tone index (VVTI), and Poincaré plot analysis. Results: In the 24-h Holter analysis, BOAS dogs showed significantly higher values than controls, particularly in cSDNN (0.365 [IQR: 0.306-0.465] vs 0.246 [IQR: 0.208-0.359] ms, P = .0058) and cRMSSD (0.476 [IQR: 0.409-0.599] vs 0.312 [IQR: 0.259-0.462] ms, P = .0119). Sleep was associated with higher cSDNN, cRMSSD, and VVTI in all groups (StateSleep estimates: 0.105 [95% CI, 0.062-0.149], 0.426 [95% CI, 0.264-0.588], and 1.758 [95% CI, 1.378-2.139], respectively; all P < .001), with no significant group-by-state interaction for these variables. Presence of BOAS was moderately correlated with the longest sinus pause (r = 0.4197, P = .0023), cSDNN (r = 0.4600, P = .0006), and cRMSSD (r = 0.4214, P = .0018). Conclusions and clinical importance: The presence of BOAS influences autonomic modulation more than the dogs’ craniofacial conformation. Differences in HRV were more pronounced in awake dogs, likely due to chronic respiratory alterations and intermittent hypoxia.